Deep Brain Stimulation (DBS) Retrospective Outcomes Study
概览
- 阶段
- 不适用
- 干预措施
- Deep Brain Stimulation
- 疾病 / 适应症
- Parkinson Disease
- 发起方
- Boston Scientific Corporation
- 入组人数
- 5000
- 试验地点
- 24
- 主要终点
- Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
- 状态
- 招募中
- 最后更新
- 上个月
概览
简要总结
The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
详细描述
The purpose of this study is to characterize 1\. real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.
研究者
入排标准
入选标准
- •Must be previously treated with or eligible for implantation with a deep brain stimulation system
排除标准
- •No Exclusion Criteria
研究组 & 干预措施
Parkinson's Disease
Subjects with Parkinson's disease, implanted with a Boston Scientific Deep Brain Stimulation System
干预措施: Deep Brain Stimulation
Essential Tremor
Subjects with Essential Tremor, implanted with a Boston Scientific Deep Brain Stimulation System
干预措施: Deep Brain Stimulation
Dystonia
Subjects with dystonia, implanted with a Boston Scientific Deep Brain Stimulation System
干预措施: Deep Brain Stimulation
结局指标
主要结局
Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline
时间窗: 5 yrs. post implant
Improvement in disease symptoms as assessed by Unified Parkinson's Disease Rating Scale (UPDRS III) at up to 5 years post implant compared to baseline